Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 01, 2025 04:07 ET | Source: Research and Markets

Antisense Oligonucleotides Market Trends Report 2025-2035: 170+ Pipeline Candidates, 30 Players and 18,000 Patients Drive Growth in Genetic, Neurological and Oncological Disorders

Dublin, Oct. 01, 2025 (GLOBE NEWSWIRE) -- The "Antisense Oligonucleotides Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Antisense Molecule, Type of ASO Generation,...
August 28, 2025 13:00 ET | Source: DelveInsight Business Research LLP

Antisense Oligonucleotide Therapeutics Clinical Trial Pipeline Appears Robust With 70+ Key Pharma Companies Actively Working in the Domain | DelveInsight

New York, USA, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Antisense Oligonucleotide Therapeutics Clinical Trial Pipeline Appears Robust With 70+ Key Pharma Companies Actively Working in the Domain |...
August 08, 2025 06:15 ET | Source: Research and Markets

Antisense Oligonucleotide Therapeutics Pipeline Market Landscape Report 2025 | Explore Clinical and Nonclinical Stages, Therapeutic Assessments, and the Future of ASO Therapies

Dublin, Aug. 08, 2025 (GLOBE NEWSWIRE) -- The "Antisense Oligonucleotide Therapeutics - Pipeline Insight, 2025" has been added to ResearchAndMarkets.com's offering. The report offers an in-depth...
May 28, 2025 06:29 ET | Source: Research and Markets

Oligonucleotide Synthesis Market Research 2025-2030 with Executive & Consultant Guides, and Profiles of 67 Key Players

Dublin, May 28, 2025 (GLOBE NEWSWIRE) -- The "Oligonucleotide Synthesis Market: Forecast by Oligo Length, Application, Category, Type, Product, and Region, with Executive and Consultant Guides"...
January 06, 2025 07:39 ET | Source: Research and Markets

Oligonucleotide Synthesis Market Report 2025: RNA-Based Vaccines, Genomic Blizzard, Antisense Revival, & New Applications Driving Growth

Dublin, Jan. 06, 2025 (GLOBE NEWSWIRE) -- The "Oligonucleotide Synthesis Market: Forecast by Oligo Length, Application, Category, Type, Product, and Region, with Executive and Consultant Guides"...
February 26, 2024 03:19 ET | Source: Research and Markets

Oligonucleotide Synthesis Market Poised for Exponential Growth in Healthcare and High-Tech Applications - New Research Report Forecasts 2023-2027 Trends and Insights

Dublin, Feb. 26, 2024 (GLOBE NEWSWIRE) -- The "Oligonucleotide Synthesis Markets - Forecasts by Oligo Length, Application, and Product - With Executive and Consultant Guides. 2023 to 2027" report...
January 31, 2024 05:59 ET | Source: Research and Markets

RNA Therapeutics Market Research Report 2023: Focus on mRNA Therapeutics, RNA Interference, Antisense Oligonucleotides - Global Forecast to 2028

Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "RNA Therapeutics Market by Product (Vaccines, Drugs), Type (mRNA Therapeutics, RNA Interference, Antisense Oligonucleotides), Indication (Infectious...
January 25, 2024 09:54 ET | Source: Research and Markets

Global mRNA Therapeutics Market Set to Reach $21 Billion by 2028 Despite Decline, Fueled by Next-Gen Drugs

Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "mRNA: Therapeutics and Global Markets" report has been added to ResearchAndMarkets.com's offering.The global market for mRNA therapeutics reached $60...
October 20, 2023 12:48 ET | Source: Visiongain Reports Ltd

Antisense Oligonucleotide (ASO) Therapeutics market is projected to grow at a CAGR of 14.5% by 2033: Visiongain

Visiongain has published a new report entitled Antisense Oligonucleotide (ASO) Therapeutics Market Report 2023-2033: Forecasts by Therapeutic Application (Neurological Disorders, Genetic Disorders,...
October 05, 2023 06:38 ET | Source: Research and Markets

Global Oligonucleotide Synthesis Markets Research Report 2023 With Executive and Consultant Guides & Forecasts to 20277

Dublin, Oct. 05, 2023 (GLOBE NEWSWIRE) -- The "Oligonucleotide Synthesis Markets - Forecasts by Oligo Length, Application, and Product - With Executive and Consultant Guides. 2023 to 2027" report...